Sessions

Lunchtime Briefing: Navigating the AI Frontier in Cell and Gene Therapy: Breaking Barriers with Innovative Technology – Accelerating Patient On-boarding and Reducing Bureaucratic Hurdles
Lunchtime Briefing: Practical Considerations for Establishing Flexible, Scalable Manufacturing
Morning Briefing: Applying Process Optimization and Process Intensification to Cell and Gene Therapy Manufacturing

Lunchtime Briefing: Navigating the AI Frontier in Cell and Gene Therapy: Breaking Barriers with Innovative Technology – Accelerating Patient On-boarding and Reducing Bureaucratic Hurdles

06 Sep 2023
12:45
Stream 4
SPONSORED BY
Hataali

Welcome Address 

Moderated by: Raja Sharif, Founder & Chief Executive Officer, ATMPS 

 

Presentation: State of the industry

Malik Kaman, Partner, ZS Consulting

 

Presentation: Introduction & launch  

Raja Sharif, Founder & CEO, ATMPS

 

Presentation: Live Product Demonstration

Martin Bornhauser,Professor, Head Of The Department For Hematology And Medical Oncology, University Hospital Dresden

 

Speaker Panel Q&A: with all session participants joined by: 

Robert Jones, Vice President, Global Bioservices, Cryoport and Amandine Breton, Director MSAT & AST, Orchard Therapeutics


 

Speakers

Raja Sharif
Founder & Chief Executive Officer
Hataali
Malik Kaman
Partner
ZS Consulting
Martin Bornhauser
Professor, Head of the Department for Hematology and Medical Oncology
University Hospital Dresden
Robert Jones
Vice President, Global Bioservices
cryoport systems
Amandine Breton
Director MSAT & AST, Cell & Gene Therapies
Orchard Therapeutics